Stem Cells , Tissue Engineering and Hematopoietic Elements Paradoxical Effects of PDGF-BB Overexpression in Endothelial Cells on Engineered Blood Vessels In Vivo
暂无分享,去创建一个
R. Jain | L. Munn | D. Fukumura | P. Au | D. Duda | Peichun Lin | Josh Tam | Pei-Chun Lin | D. Duda
[1] P. Allavena,et al. Macrophage polarization in tumour progression. , 2008, Seminars in cancer biology.
[2] Jianhua Huang,et al. A Role for VEGF as a Negative Regulator of Pericyte Function and Vessel Maturation , 2008, Nature.
[3] F. Petersen,et al. Platelet factor 4/CXCL4‐stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals , 2008, Journal of leukocyte biology.
[4] L. Naldini,et al. Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. , 2007, Cancer research.
[5] L. Ellis,et al. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. , 2007, The Journal of clinical investigation.
[6] R. Jain,et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo , 2007, Nature Biotechnology.
[7] M. Berger,et al. Intracranial Microenvironment Reveals Independent Opposing Functions of Host αVβ3 Expression on Glioma Growth and Angiogenesis* , 2006, Journal of Biological Chemistry.
[8] M. Berger,et al. Intracranial microenvironment reveals independent opposing functions of host alphaVbeta3 expression on glioma growth and angiogenesis. , 2006, The Journal of biological chemistry.
[9] Bin Zhou,et al. Endothelial progenitor cells transfected with PDGF: cellular and molecular targets for prevention of diabetic microangiopathy. , 2006, Medical hypotheses.
[10] Peter Carmeliet,et al. Angiogenesis in life, disease and medicine , 2005, Nature.
[11] Dai Fukumura,et al. Engineering vascularized tissue , 2005, Nature Biotechnology.
[12] M. Simons. Angiogenesis: where do we stand now? , 2005, Circulation.
[13] Stefanie Dimmeler,et al. Unchain my heart: the scientific foundations of cardiac repair. , 2005, The Journal of clinical investigation.
[14] C. Betsholtz. Insight into the physiological functions of PDGF through genetic studies in mice. , 2004, Cytokine & growth factor reviews.
[15] G. Owens,et al. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.
[16] Minoru Takemoto,et al. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities , 2004, Development.
[17] Dai Fukumura,et al. Tissue engineering: Creation of long-lasting blood vessels , 2004, Nature.
[18] M. F. Booth,et al. What brings pericytes to tumor vessels? , 2003, The Journal of clinical investigation.
[19] U. Landegren,et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. , 2003, Genes & development.
[20] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[21] Seung-Hoon Lee,et al. Vascular Endothelial Growth Factor Modulates Neutrophil Transendothelial Migration via Up-regulation of Interleukin-8 in Human Brain Microvascular Endothelial Cells* , 2002, The Journal of Biological Chemistry.
[22] C. Betsholtz,et al. Platelet-derived growth factor B-chain of hematopoietic origin is not necessary for granulation tissue formation and its absence enhances vascularization. , 2001, The American journal of pathology.
[23] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[24] L. Ellis,et al. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] J. Waltenberger. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. , 2001, Cardiovascular research.
[26] T. Murohara,et al. Hyperhomocysteinemia Impairs Angiogenesis in Response to Hindlimb Ischemia , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[27] I. Buschmann,et al. Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. , 2000, European journal of cell biology.
[28] Dian Feng,et al. Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor , 2000, Laboratory Investigation.
[29] R K Jain,et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. , 1998, The Journal of investigative dermatology.
[30] K. Hirschi,et al. PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate , 1998, The Journal of cell biology.
[31] K. Hirschi,et al. Pericytes in the microvasculature. , 1996, Cardiovascular research.
[32] R. Jain,et al. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. , 1996, Nature medicine.
[33] R K Jain,et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.
[34] W. Risau,et al. Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro , 1987, The Journal of cell biology.